MM often goes undetected until its later stages because it presents with non-specific symptoms, including fatigue, weight loss, bone pain, and recurrent infections. 2,3 However, better awareness, ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
The LINKER-SMM1 trial shows promising results for linvoseltamab in treating high-risk smoldering multiple myeloma with a favorable safety profile, notes Paula Rodríguez-Otero, MD, PhD.
CHICAGO — In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis. “Teclistamab has already been ...
Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence. Despite its rarity and the lack of recognition by the World Health Organization as a ...
Their patient developed FGN as the plasma cell neoplasm progressed from MGUS to multiple myeloma. Histopathology findings pointed to classical FGN with no indications of myeloma cast/light chain cast ...
Data were analysed using SPSS 17.0 for Windows. Spearman's correlation coefficient was used to assess the correlation of results between the two assays and Chi square test to assess the classification ...
When Sally Cox was diagnosed with light chain amyloidosis (AL) in 2019, she was shocked. Not only had she never heard of the rare disease that causes abnormal proteins (or amyloids) to build up in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback